Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gsk Plc ADR (GSK)

Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 92,140,680
  • Shares Outstanding, K 2,072,440
  • Annual Sales, $ 37,725 M
  • Annual Income, $ 6,130 M
  • 60-Month Beta 0.65
  • Price/Sales 2.45
  • Price/Cash Flow 8.68
  • Price/Book 5.56
Trade GSK with:

Options Overview Details

View History
  • Implied Volatility 21.27% ( +2.12%)
  • Historical Volatility 17.83%
  • IV Percentile 74%
  • IV Rank 61.38%
  • IV High 27.36% on 04/29/24
  • IV Low 11.60% on 03/11/24
  • Put/Call Vol Ratio 0.12
  • Today's Volume 16,066
  • Volume Avg (30-Day) 14,363
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 108,534
  • Open Int (30-Day) 109,932

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.01
  • Number of Estimates 3
  • High Estimate 1.10
  • Low Estimate 0.96
  • Prior Year 0.97
  • Growth Rate Est. (year over year) +4.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.60 +12.43%
on 04/23/24
45.92 -0.61%
on 05/15/24
+5.06 (+12.45%)
since 04/22/24
3-Month
39.15 +16.58%
on 04/18/24
45.92 -0.61%
on 05/15/24
+3.49 (+8.27%)
since 02/22/24
52-Week
33.33 +36.95%
on 06/01/23
45.92 -0.61%
on 05/15/24
+10.30 (+29.12%)
since 05/22/23

Most Recent Stories

More News
Option Volatility And Earnings Report For May 13- 17

Earnings season is slowing down, but we still have a few big names reporting. This week, we have Alibaba, Home Depot, Walmart, Cisco and Deere & Company all reporting.

BABA : 83.16 (-3.45%)
HD : 330.26 (-1.75%)
WMT : 65.20 (+0.08%)
CSCO : 47.44 (+1.07%)
DE : 385.53 (-0.31%)
COIN : 227.83 (+0.91%)
RIOT : 10.66 (+0.47%)
GSK : 45.55 (+2.45%)
ZM : 64.00 (+0.22%)
CCJ : 52.43 (-2.42%)
TSLA : 178.73 (-4.22%)
CHWY : 16.43 (-1.62%)
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN.LN : 12,358.001 (-0.05%)
AZN : 78.71 (-0.59%)
GSK.LN : 1,788.500 (+1.85%)
GSK : 45.55 (+2.45%)
Down 75%. Is Agenus Stock a Buy on the Dip?

Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.

RILY : 32.63 (+8.15%)
MRK : 131.21 (+0.34%)
BMY : 42.51 (+0.57%)
GSK : 45.55 (+2.45%)
AGEN : 12.22 (+9.89%)
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?

These stocks could rocket higher, but they also present significant risks.

BMY : 42.51 (+0.57%)
GSK : 45.55 (+2.45%)
RILY : 32.63 (+8.15%)
DNA : 0.7076 (-3.24%)
AGEN : 12.22 (+9.89%)
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.

ME : 0.5006 (-5.55%)
GSK : 45.55 (+2.45%)
Find Therapeutics Announces Appointment of Dr. Anthony Johnson to its Board of Directors

/CNW/ - Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced that...

GSK : 45.55 (+2.45%)
Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe

The renowned brokerage firm weighed in on its top stock picks from the European market, which could offer investors better value than the outsized GRANOLAS group of equities at current levels.

NVDA : 937.20 (-1.75%)
MSFT : 428.48 (-0.13%)
AMZN : 182.62 (-0.29%)
AAPL : 190.75 (-0.83%)
META : 468.13 (+0.75%)
GOOGL : 175.82 (-1.14%)
TSLA : 178.73 (-4.22%)
GS : 461.55 (-1.88%)
GSK : 45.55 (+2.45%)
RHHBY : 31.7150 (-1.87%)
NSRGY : 103.8775 (-0.76%)
NVS : 101.80 (-1.01%)
1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

GSK : 45.55 (+2.45%)
HLN : 8.51 (-0.12%)
2 Best Growth Stocks to Buy with $1,000 Right Now

Growth stocks are getting ready for a comeback year in 2024, and these two under-the-radar stocks have solid financials and significant upside potential.

GSK : 45.55 (+2.45%)
1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach...

MRNA : 159.71 (+11.15%)
GSK : 45.55 (+2.45%)
HLN : 8.51 (-0.12%)
CVS : 57.30 (-0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 44.89
2nd Resistance Point 44.81
1st Resistance Point 44.63
Last Price 45.55
1st Support Level 44.37
2nd Support Level 44.29
3rd Support Level 44.11

See More

52-Week High 45.92
Last Price 45.55
Fibonacci 61.8% 41.11
Fibonacci 50% 39.63
Fibonacci 38.2% 38.14
52-Week Low 33.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar